One thing coming out of the Covid-19 crisis that was glaringly exposed was the almost total reliance of the U.S. on China for prescription drugs - even the ingredients to make them. The obvious answer was to on-shore production again and President Trump promised to do just that.
It was just announced that a Defense Department Production Act loan of $765M is being made to Eastman Kodak to launch "Eastman Pharmaceuticals" to begin making the base ingredients for generic drugs. The company has seen hard times with the almost total transition to digital photography, but retains considerable expertise with chemicals. If the drug ingredients are made at Eastman's complex in Rochester, NY, it will also be a boon with new high-end jobs back in this country. A double win for all concerned.
No comments:
Post a Comment